Latest Breaking News On - Vhl disease associated cancers - Page 1 : vimarsana.com

Jaleh Fallah, MD, discusses the FDA's evaluation of data from the phase 2 LITESPARK-004 trial, which supported the approval of belzutifan in von Hippel-Lindau–associated cancers.

Jaleh fallahInternational kidney cancer symposiumDivision of ophthalmologyNational institutes of healthKidney cancer symposiumNational institutesRenal cell carcinomaVon hippel lindauVhl disease associated cancers